Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

The combination of encorafenib and binimetinib caused few skin issues.

Baricitinib was effective in treating both early and late onset alopecia areata.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib helped a woman regrow hair with no major side effects.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Tangent screens help detect visual field defects from vigabatrin.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Compound 1 showed promising anticancer activity.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

A3B5 can reduce skin pigmentation and slow melanoma growth.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.